Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Aventis characterizes potential novel antiasthmatic agent

Sep. 5, 2000

ZD-6021: a potent, orally active tachykinin receptor antagonist

Sep. 5, 2000

ACS news: selective inhibitors of ICAM-1/E-selectin expression exerting antiinflammatory activity

Sep. 5, 2000

Ebselen as a new therapeutic agent for asthma

Sep. 5, 2000

Novel treatment for asthma --an IL-4/IL-13 receptor antagonist-- characterized at ERS meeting

Sep. 5, 2000

New PDE4 inhibitors from Byk Gulden useful for respiratory disorders

Sep. 4, 2000

Patent covers SB's new antiallergic agents acting on chemokine receptors

Sep. 4, 2000

Antiinflammatory compounds with macrolide structure designed by Zambon

Sep. 4, 2000

ERS highlights: orazipone prevents eosinophilia in animal models of lung inflammation

Sep. 4, 2000

Beneficial effects of PAF antagonist in patients with bronchial asthma

Sep. 4, 2000

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...